share_log

TransCode Therapeutics Shares Are Trading Higher After the Company Announced It's Dosed Patients in the First Cohort of Its Phase 1A Dose-escalation Clinical Trial of TTX-MC138.

Benzinga ·  Oct 10 10:20
TransCode Therapeutics Shares Are Trading Higher After the Company Announced It's Dosed Patients in the First Cohort of Its Phase 1A Dose-escalation Clinical Trial of TTX-MC138.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment